|Bid||40.34 x 1300|
|Ask||40.35 x 1200|
|Day's Range||39.84 - 40.12|
|52 Week Range||32.98 - 46.67|
|Beta (3Y Monthly)||1.16|
|PE Ratio (TTM)||25.33|
|Forward Dividend & Yield||0.96 (2.23%)|
|1y Target Est||44.55|
May 23, 2019 Large Midwest laboratory selects Philips IntelliSite Pathology Solution to further enhance efficiencies and quality of diagnostics for histology cases.
As Koninklijke Philips N.V. (AMS:PHIA) announced its earnings release on 31 March 2019, it seems that analyst...
May 20, 2019 Integrating best-in-class physiology, imaging and co-registration tools across the interventional lab workflow supports physicians in providing cardiac and.
The U.S. FBI is investigating corporate giants Johnson & Johnson, Siemens AG, General Electric Co and Philips for allegedly paying kickbacks as part of a scheme involving medical equipment sales in Brazil, two Brazilian investigators have told Reuters. Brazilian prosecutors suspect the companies channelled illegal payoffs to government officials to secure contracts with public health programs across the South American country over the past two decades. Brazilian authorities say more than 20 companies may have been part of a "cartel" that paid bribes and charged the government inflated prices for medical gear such as magnetic resonance imaging machines and prosthetics.
The U.S. FBI is investigating corporate giants Johnson & Johnson, Siemens AG, General Electric Co and Philips for allegedly paying kickbacks as part of a scheme involving medical equipment sales in Brazil, two Brazilian investigators have told Reuters. Brazilian prosecutors suspect the companies channeled illegal payoffs to government officials to secure contracts with public health programs across the South American country over the past two decades. Brazilian authorities say more than 20 companies may have been part of a "cartel" that paid bribes and charged the government inflated prices for medical gear such as magnetic resonance imaging machines and prosthetics.
Announcement of Periodic Review: Moody's announces completion of a periodic review of ratings of Royal Philips N.V. Frankfurt am Main, May 17, 2019 -- Moody's Investors Service ("Moody's") has completed a periodic review of the ratings of Royal Philips N.V. and other ratings that are associated with the same analytical unit. The review was conducted through a portfolio review in which Moody's reassessed the appropriateness of the ratings in the context of the relevant principal methodology(ies), recent developments, and a comparison of the financial and operating profile to similarly rated peers.
Following the opening of the Windpark Krammer in the southwest of the Netherlands in the presence of His Majesty King Willem-Alexander, Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, achieved another major milestone on the road to becoming carbon neutral by 2020. Under the terms of a power purchase agreement (PPA) between the windfarm’s operators and the Dutch Wind Consortium – a joint initiative by Philips, DSM, Google and Nouryon (formerly AkzoNobel Specialty Chemicals) – the consortium partners will jointly purchase 95% of the wind park’s total 102 MW output (generated by 34 wind turbines) for the next 15 years.
Royal Philips (NYSE: PHG, AEX: PHIA) (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the successful pricing of its issuance of EUR 750 million 0.500% Green Innovation Bonds due 2026. This inaugural Green Innovation Bond was created by Philips in collaboration with Rabobank as Sustainability Structuring Advisor. The transaction was further supported by the Joint Lead Managers ABN AMRO, BNP Paribas, Deutsche Bank, HSBC, ING, Mizuho Securities, MUFG, Rabobank and UBS Investment Bank.
Royal Philips (NYSE: PHG, AEX: PHIA) a leading global health technology company, has announced it signed a 10-year strategic partnership agreement with Rutherford Diagnostics. This collaboration will utilize Philips innovative radiology technology and Rutherford Diagnostics’ healthcare expertise to deliver and operate advanced personalized diagnostic services through a network of community diagnostic centers, driving the best possible healthcare outcomes for patients.
May 9, 2019 Philips’ integrated solution will combine the unique KODEX-EPD dielectric imaging and navigation system, dielectric imaging sensors, clinical.
May 9, 2018 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA) announced that today’s Annual General Meeting of Shareholders (AGM) re-appointed Frans van.
Philips North America has sold its Andover campus ahead of the company’s move to Cambridge Crossing next year.
Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! Every investor in Koninklijke Philips N.V. (AMS:PHIA) should be aware of the most powerful shareholde...
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that telehealth service provider Chipmunk Health, with locations in the Netherlands and Canada, is leveraging the capabilities and services of Philips’ HealthSuite digital platform to roll out its new GP-to-patient home monitoring solutions.
Philips' (PHG) first-quarter 2019 results benefit from higher sales from Personal Health and Diagnosis & Treatment businesses.
“There are many, many sources for developing this talent, but not all of us can afford [a recruiter] … which is what it’s going to take in some cases to build out a full complement of an analytics team.” said IQuity Chief Financial Officer Julia Polk.
Dutch health technology company Philips said on Monday it expects sales to accelerate in coming months on improved demand in Europe and the United States after a weak first quarter. A decline in demand for hospital equipment in Europe and flat sales in the United States capped overall comparable quarterly sales growth to 2.3 percent, even though results in China and other emerging markets were much more upbeat. The maker of healthcare products which range from high-tech toothbrushes to medical imaging systems, stuck to its target of 4 to 6 percent annual sales growth until 2020, saying demand in Europe and the U.S. will pick up rapidly.
On a per-share basis, the Amsterdam-based company said it had profit of 20 cents. Earnings, adjusted for non-recurring costs and to account for discontinued operations, were 33 cents per share. The medical ...
The maker of body scanners, imaging products and respiratory gear stepped up launches and increased marketing to counter weaker consumer confidence in markets like China. It reported first-quarter adjusted earnings before interest, taxes and amortization increased 5.8 percent to 364 million euros ($405.6 million). Key InsightsThe personal health segment and emerging markets generally are performing well, but mature markets are off to “a slower start” to the year, Chief Executive Officer Frans van Houten said on a call to reporters.